IN2014DN03220A - - Google Patents

Download PDF

Info

Publication number
IN2014DN03220A
IN2014DN03220A IN3220DEN2014A IN2014DN03220A IN 2014DN03220 A IN2014DN03220 A IN 2014DN03220A IN 3220DEN2014 A IN3220DEN2014 A IN 3220DEN2014A IN 2014DN03220 A IN2014DN03220 A IN 2014DN03220A
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Yoshihiro Ishikawa
Original Assignee
Ihi Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ihi Corp filed Critical Ihi Corp
Publication of IN2014DN03220A publication Critical patent/IN2014DN03220A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN3220DEN2014 2011-10-04 2014-04-22 IN2014DN03220A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011220449 2011-10-04
PCT/JP2012/073900 WO2013051389A1 (ja) 2011-10-04 2012-09-19 金属サレン錯体化合物応答性薬剤及び金属サレン錯体化合物の体内挙動制御システム

Publications (1)

Publication Number Publication Date
IN2014DN03220A true IN2014DN03220A (ja) 2015-06-26

Family

ID=48043553

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3220DEN2014 IN2014DN03220A (ja) 2011-10-04 2014-04-22

Country Status (8)

Country Link
US (1) US9468621B2 (ja)
EP (1) EP2764873B1 (ja)
JP (1) JP6155190B2 (ja)
CN (1) CN104010660A (ja)
IN (1) IN2014DN03220A (ja)
RU (1) RU2595840C2 (ja)
SG (1) SG11201401289YA (ja)
WO (1) WO2013051389A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3082922C (en) 2017-11-22 2024-02-13 National University Corporation Kobe University Complex for genome editing having stability and few side-effects, and nucleic acid coding same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5403834A (en) 1992-12-07 1995-04-04 Eukarion, Inc. Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
DE69429507T2 (de) 1993-01-29 2002-05-16 Ferx Inc Magnetisch reagierende zusammensetzung als träger für biologisch aktive substanzen und verfahren für ihre herstellung und verwendung
EP2036550A4 (en) 2006-06-28 2009-07-15 Ihi Corp MEDICAMENT, DRUG DELIVERY DEVICE, MAGNETIC DETECTOR, AND DRUG DESIGN METHOD
JP5170403B2 (ja) 2008-03-14 2013-03-27 国立大学法人 筑波大学 細菌の増殖を制御する化合物及びその応用
JP5678662B2 (ja) 2008-11-18 2015-03-04 日本電気株式会社 沸騰冷却装置
WO2010058280A1 (ja) * 2008-11-20 2010-05-27 株式会社Ihi 自己磁性金属サレン錯体化合物

Also Published As

Publication number Publication date
EP2764873A1 (en) 2014-08-13
CN104010660A (zh) 2014-08-27
JPWO2013051389A1 (ja) 2015-03-30
RU2595840C2 (ru) 2016-08-27
US20140235684A1 (en) 2014-08-21
JP6155190B2 (ja) 2017-06-28
EP2764873B1 (en) 2018-04-25
EP2764873A4 (en) 2015-04-22
WO2013051389A1 (ja) 2013-04-11
RU2014117713A (ru) 2015-11-10
US9468621B2 (en) 2016-10-18
SG11201401289YA (en) 2014-07-30

Similar Documents

Publication Publication Date Title
BR112013031251A2 (ja)
BR112013027245A2 (ja)
BR112013024383A2 (ja)
BR112013026905A2 (ja)
BR112013026744A2 (ja)
BR112013023927A2 (ja)
BR112013027830A2 (ja)
BR112013024365A2 (ja)
BR112013028733A2 (ja)
BR112013027121A2 (ja)
BR112013027452A2 (ja)
BR112013031556A2 (ja)
BR112013026790A2 (ja)
BR112013024588A2 (ja)
BR112013032380A2 (ja)
BR112013032377A2 (ja)
BR112013032366A2 (ja)
BR112013026895A2 (ja)
BR112013027761A2 (ja)
BR112013027836A2 (ja)
BR112013023266A2 (ja)
BR112013032392A2 (ja)
BR112013025487A2 (ja)
BR112013027871A2 (ja)
BR112013026861A2 (ja)